- Case report
- Open Access
Atypical/Nor98 scrapie in the Basque Country: a case report of eight outbreaks
BMC Veterinary Researchvolume 6, Article number: 17 (2010)
Since 2002, an active surveillance program for transmissible spongiform encephalopathy in small ruminants in European Union countries allowed identification of a considerable number of atypical cases with similarities to the previously identified atypical scrapie cases termed Nor98.
Here we report molecular and neuropathological features of eight atypical/Nor98 scrapie cases detected between 2002 and 2009. Significant features of the affected sheep included: their relatively high ages (mean age 7.9 years, range between 4.3 and 12.8), their breed (all Latxa) and their PRNP genotypes (AFRQ/ALRQ, ALRR/ALRQ, AFRQ/AFRQ, AFRQ/AHQ, ALRQ/ALRH, ALRQ/ALRQ). All the sheep were confirmed as atypical scrapie by immunohistochemistry and immunoblotting. Two cases presented more PrP immunolabelling in cerebral cortex than in cerebellum.
This work indicates that atypical scrapie constitutes the most common small ruminant transmissible spongiform encephalopathy form in Latxa sheep in the Spanish Basque Country. Moreover, a new genotype (ALRQ/ALRH) was found associated to atypical scrapie.
Since 2002, an active surveillance program for Transmissible Spongiform Encephalopathy (TSE) in small ruminants has been implemented in European Union countries. As a result of this program, an atypical type of scrapie different from classical scrapie (CS) and similar if not identical to Nor98 identified in Norway  was detected in most of the European countries.
CS is the traditional form of TSE affecting small ruminants, which was first detected in England around 1730 and thereafter in Germany and France [1–3]. Since then, the spread of the disease happened mainly because of the commerce and movement of sheep incubating the disease . Nowadays, the disease is present in many countries of the European Union, as well as in Canada, the United States of America, Brazil, Ethiopia and Japan [5–9]. Only Australia and New Zealand are currently considered "scrapie free" since they have successfully eradicated the classical form of the disease . CS is characterized by transmission under natural conditions causing localised outbreaks with generally a high number of animals affected in certain geographical areas . The lesions in the Central Nervous System (CNS) are neuronal and/or neuropil vacuolation of the brainstem, mainly at the obex region, involving the dorsal motor nucleus of the vagus (DMNV) and also the spinal tract of the trigeminal nerve. Accumulation of the disease-associated abnormal prion protein (PrPSc) is observed primarily in glial cells (astrocytes) and neurons [11, 12]. The most susceptible alleles to CS are VRQ and ARQ and the most resistant ARR [13–16]. The biochemical signature of PrPSc is characterized by a three band pattern between 18 and 30 kDa .
Atypical/Nor98 scrapie (AS/Nor98), by contrast, seems to occur sporadically or to be minimally contagious . In the majority of the cases, AS/Nor98 is detected only in a single sheep per flock [1, 19, 20]. It is distributed throughout a whole country [10, 21] and its prevalence does not seem to vary through time . AS/Nor98 agent has been shown to be experimentally transmissible, though at low efficiency, to sheep  and to transgenic mice expressing ovine  and porcine PrP . However, its spread under natural conditions seems not to follow the same pattern as CS. Examination of British demographic factors and trading patterns has suggested that transmission of AS/Nor98 could occur, albeit at very low rate . Two case-control studies of Nor98 in Norway and France found no risk factors to indicate transmission between flocks [21, 27]. Neuropathologically, the PrPSc distribution pattern in the brain is characterised, in the majority of cases, by massive accumulations of PrPSc in cerebellum and cerebrum [1, 28–32] and by the absence of deposition of PrPSc in the DMNV at the level of the obex [1, 28, 29, 31–33]. Additionally, in some of the cases, PrPSc has been detected in the nucleus of the spinal tract of the trigeminal nerve [30, 34, 35]. Occasionally, the only presence of PrPSc immunostaining at the level of the obex appears to be a globular staining in the white matter tracts  while no intracellular immunolabelling in the central or peripheral nervous tissue has been observed in natural AS/Nor98 [31, 37, 38]. Genotypic features show that the PrP genotypes affected by AS/Nor98 are different from classical scrapie [10, 20, 33, 35, 39–43], the PrP alleles (136/141/154//171) ALHQ, AFRQ and ARR being the most frequently affected . Biochemically, PrPSc of AS/Nor98 shows two characteristic features: one, the electrophoretic profile with a multiple band pattern and a characteristic band of low molecular weight (lower that 14 kDa), and the other one, a lower resistance to PK than PrPSc from CS [1, 33, 36, 44].
Detection and identification of AS has been increasing since 1998, when Nor98 was first detected . Various studies report AS/Nor98 cases in Belgium, The Falkland Islands, France, Germany, Ireland, Norway, Portugal, Sweden, UK, North America and Poland [1, 19, 29, 32–35, 39, 45–50]. Besides, two recent studies based on active surveillance data from European countries report cases of AS in other countries such as Spain, Italy, Netherlands, Finland, Denmark and Switzerland [51, 52]. In some of the countries where AS/Nor98 is reported, this form appears to be the most frequent if not the only one, as newly announced in New Zealand (media release appeared in http://www.biosecurity.govt.nz/media/28-10-09/atypical-scrapie-detection), and as observed in Poland where it constitutes the only small ruminant TSE detected .
In Spain, the proportion of AS/Nor98 cases increased considerably from 2% to 14% between 2004 and 2007 (Report on the monitoring and testing of ruminants for the presence of transmissible spongiform encephalopathy (TSE) in the EU in 2007) http://ec.europa.eu/food/food/biosafety/bse/annual_reps_en.htm. However, the monitoring requirements have changed during this period and it is highly probable that the testing and sampling methods have influenced the detection of these cases. Nevertheless, attention must be paid from now on to confirm whether AS/Nor98 tends to increase or remains constant along time.
The Latxa breed (called Manech in France) is the native breed of sheep in the Basque Country and it is bred for Idiazabal-type cheese production . There are two varieties, black-faced Latxa and fair-faced Latxa that together constitute approximately 85% of the sheep population in the Spanish Basque Country [54, 55].
Here we report molecular and neuropathological features of eight cases of AS/Nor98 detected between 2002 and 2009, and showing that AS/Nor98 is the most common small ruminant TSE form in Latxa breed sheep in the Spanish Basque Country.
Between 2002 and 2008 the mean number of sheep analysed per year in the Basque Country was 764 and until September 2009, the total number of animals screened added up to 5620. Of these, eight Latxa ewes with molecular and pathological features of AS/Nor98 were found. The cases were detected widely distributed within this region and amounted to a significantly (p = 0.0196) higher prevalence (0.15%) than that of classical scrapie (0.02%) (Table 1). The first two cases were fallen stock and appeared in 2004, the third one was a slaughtered ewe tested in 2005 that was confirmed by Western blotting as Nor98 at the Norwegian National Veterinary Institute. The three following cases were detected in 2008, the first two cases at the beginning of the year and the third at the end of the year. The two last cases were detected at the beginning of 2009 and had been slaughtered for human consumption. Clinical symptoms were reported in only one of the cases (M31 (2008)). It drew the attention of the veterinary inspector at the slaughterhouse because it showed slight neurological signs such as ataxia, and poor condition. There were no further veterinary inspection reports of clinical signs for the remaining slaughtered animals or any of the fallen stock. In this context, it needs to be emphasized that due to frequent lack of clinical records as a consequence of the inefficiency of passive surveillance, there is no adequate clinical information on these scrapie cases in general. The mean age of all the eight cases was 7.9 years (range between 4.3 and 12.8).
Results of rapid test, immunoblot analyses and genotyping are shown in detail in Table 2. The homogenates originally tested by rapid tests were made from a pool of obex and cerebellum tissues and the optical densities varied from 0.363 to 2.859. Immunoblot analyses with Prionics Check Western revealed that 6H4 monoclonal antibody failed to detect abnormal prion protein in all cases. We replaced this antibody by P4 mAb and obtained then a very weak signal (data not shown). The best signal in western blot was achieved with TeSeE Western blot (Bio-Rad), where the PrPSc profile showed the characteristic multiband pattern clearly different from those of the classical scrapie cases (Figure 1). The analysis of different brain regions (when possible) by TeSeE Western blot revealed the strongest signal from the cerebellar tissues for all the cases except for M27 (Figure 1C) and M15 (Figure 1D), where the cerebrum presented a more intense PrPSc signal than the cerebellum. Although case M7 showed an extremely faint PrPSc signal in the obex region and no staining in the cerebellum, the case was positive in the rapid test, and then it was confirmed positive by immunohistochemistry at the National Reference Centre for TSE in Zaragoza.
PrP genotyping showed variability in genotypes. All animals were AA136 and no VV136 alleles were found. AF141RQ was the most frequent (7/16) allele followed by AL141RQ (5/16). Moreover, in combination with wild type (ALRQ), a single allele of AL141RR and AL141RH was also found. A novel AS allele involvement was found for case M9-1, which had allele AL141HQ; however this was combined with F141 in the other allele which is a susceptibility codon for AS.
Immunohistochemical analyses were performed in the cerebellum, frontal lobe and medulla oblongata with a mix of mAb F89/160.1.5 and 2G11. In all five cases where the cerebellum was available (M72, M45, M31, M9-1 and M9-2), this was the brain region where PrPSc deposits were more abundant. The type of deposits were rather homogeneous and diffuse, predominating the fine granular staining in the cortical layers and with the molecular layer showing a more prominent signal than the granular layers (Figure 2A). Punctate aggregates, plaque-like and linear deposits were also present in the molecular layer. The cerebrum of three available cases showed punctate staining in the deeper cortex (M45 and M9-1) and a fine granular laminar pattern (M9-2). Basal nuclei, when present (M45) showed intense punctate and fine granular signal. In the medulla oblongata the deposits were punctate and fine granular in the neuropil of nuclei, especially in the spinal tract of trigeminal nerve. In the three different areas, the white matter showed variable degrees of punctate, globular aggregates, or plaque like PrPSc deposits. In the cerebrum, this signal in the white matter was in some cases (M45 and M9-1) more prominent than in the grey matter.
Remarkable differences were found in M15 and M27 cases in which the sample from frontal cerebrum showed the strongest signal (Figure 2B) and the cerebellar immunolabelling pattern was dissimilar comparing to other AS cases. The immunostaining of cerebellum of both cases showed scant deposits in the granular layer but more prominent than in the molecular (Figure 2C and 2D). In the frontal lobe, M15 showed fine granular staining in a three band laminar pattern in cortex (Figure 2E), whereas in M27 the deeper layers of the cortex showed punctate immunostaining. The basal nuclei showed punctate pattern when present (M15). No differences were found in the medulla oblongata in relation with the rest of the cases. Apart from these two cases, M7 sample was in poor condition and showed scant immunostaining in the granular layer of the cerebellum. This result could be related with an excessive tissue fixation (during 5 years in this case) of the sections as recently observed when stained with different antibodies like mAb 2G11 and F89/160.1.5 .
We described eight atypical scrapie cases detected between 2002 and 2009 from the Basque Country. All AS/Nor98 cases were found in Latxa sheep which breed represents 85% of the Basque Country sheep population [54, 55, 57]. The occurrence of these cases seemed to be random and, in agreement with other AS surveillance studies , there was no apparent temporal trend. Geographically, the distribution of atypical scrapie cases was in accordance with that described in other regions of the world. First, a single positive sheep per affected flock was detected, as observed in the majority of other AS cases [1, 19, 20]. Second, they presented a wide distribution in the Basque Country, with reports of cases in all three provinces. At this point it should be mentioned that the highest proportion was observed in Guipuzcoa (62.5%) but it may be due to the fact that it constituted the province with the highest rate of sheep slaughter (over 90%) analysed in the Basque Country. Nevertheless, the sample size was still too small to draw any definite conclusion. Moreover, the occurrence of atypical scrapie cases pointed to an absence of time clustering, since there were long periods with no detection of cases and then, within a few months 2 or 3 affected animals were detected. However, it must be taken into consideration that, (i) not all sheep older than 18 months of age were analysed as a consequence of the random sampling procedure contrary to the exhaustive one legislated for cattle, (ii) the brain sampling may not have been optimal, e.g. only the medulla oblongata was collected or, particularly in the case of fallen stock, the brain samples were sometimes severely autolytic and liquefied, thus increasing the chances of sampling an area where PrPSc was absent, (iii) due to the young age of some animals, the stage of the disease, the small sampling site and the relatively low number of animals and short period of time involved, the possibility of longer and more tenuous temporal and spatial trends in PrPSc distribution could not be excluded. For these reasons, the number of AS and CS cases may be underrepresented and could suffer from a certain bias.
One of the cases (M45) described here was confirmed to be Nor98. PrPSc deposition, distribution and molecular profile of the cases M72, M31, M15, M9-1 and M9-2 were identical to the features of this Nor98-confirmed case and to previous descriptions [1, 38]. Moreover, the mean age observed was in accordance to other observations for atypical scrapie . Among some of the features our cases had in common with M45, the following should be emphasised: i) the molecular protein profile showed a characteristic low molecular weight band under 14 kDa, ii) the cerebellum was the most affected region, iii) PrPSc was mainly detected in the neuropil predominantly as fine granular deposits, and iv) a faint to moderate PrPSc signal intensity was seen. The detection of more intense PrPSc deposits in cerebellum or cerebral cortex rather than in the medulla oblongata may indicate that the prion is likely not to enter the brain through the medulla (DMNV) as described for classical scrapie , thus suggesting a rather sporadic aetiology, as observed in human sporadic TSE cases. Cases M15 and M27 however, presented some differences. Albeit PrPSc molecular pattern was similar to the Nor98 confirmed case, both animals showed more PrPSc deposits in the frontal lobe of cerebral cortex than in the cerebellum by immunohistochemistry (IHC) and also by immunoblot (WB) for case M27. By contrast, case M15 showed small differences between IHC and WB results since the signal in the pooled obex and cerebellum in WB was more intense than in the cerebellum and medulla oblongata in IHC. This could have been biased by the sampling for frozen tissues and by severe tissue autolysis and could be the explanation for a negative and extremely faint PrPSc signal in WB of case M7 in the cerebellum and obex, respectively. The fact that these cases showed more PrPSc accumulation in cerebral cortex than in cerebellum might be influenced by other still unknown environmental or genetics factors. Alternatively, this might happen more commonly than observed because of the limited number of AS/Nor98 cases where both the cerebellar and the cerebral cortices are available for analysis. When the sampling of brain is carried out with a spoon through the foramen magnum some cerebellum can also be collected along with the medulla oblongata and this can be targeted as the optimum sample for WB testing, particularly if the IHC results indicate a possible atypical scrapie case. Unfortunately, cerebrum is not routinely collected by this method so little is known about its PrPSc status. The availability of this brain region for M7 would have been useful to clear up any doubt on its diagnosis and classification. This case was questionable because we did not obtain a clear pattern in the WB with the band lower than 14 kDa size and because the detected signal in the cerebellum by means of IHC was extremely faint. The poor condition of the sample and the scant material available did not allow us to obtain, after repetitions of the analyses, a clear evidence of being an AS/Nor98 case. The fact that it was confirmed for the National Reference Laboratory allowed arguing that it was a scrapie case. Besides, there were several features supporting it as an atypical scrapie case. First, for CS, we would have expected to obtain a more intense signal in the WB and a clear three bands pattern of PrPSc in the region of the obex . Second, even not having an optimal signal in the WB that showed the lower band characteristic of atypical cases and having evidences according to which the case was positive by means of IHC and rapid test, the possibility of an atypical scrapie case should not be excluded. In this case, it could have happened that there was little amount of abnormal PrPSc so that after PK digestion the amount of resistant PrPSc was reduced considerably below the detection threshold of WB, as observed in the cerebellum of case M15. Third, the age of this sheep was higher than the mean age of CS cases described in Latxa breed  and in other breeds [60, 61]. Finally, this was the only detected case in its herd, which was in agreement with the epidemiology of the AS/Nor98 [1, 19, 20].
The majority of PrP genotypes described herein were observed in other AS/Nor98 cases . We found an over-representation of animals carrying AF141RQ and AL141RQ alleles, suggesting that these alleles may confer more susceptibility to atypical scrapie in Latxa breed sheep. We also described a novel genotype associated to AS that has not been previously described (AL141RQ/AL141RH).
Case reports from this study and other case reports from Spain http://www.eeb.es/pags/espana.htm and Portugal , indicate a high frequency of atypical cases compared to CS outbreaks in the Iberian Peninsula. It could be speculated that AS/Nor98 is the traditional form of scrapie in the Iberian part of the Basque country, whilst in the French part, the classical form has been predominant . This would point to some unidentified epidemiological features limiting the spread of classical scrapie in the Iberian Peninsula. However, since the analysis of all sheep can not be guaranteed, it is difficult to test this hypothesis. The analysis of all sheep would provide more information about the epidemiology and pathology of this disease. Moreover, it could contribute in assessing whether AS is present in the Basque Country with the same high frequencies as others human TSEs, such as sporadic Creutzfeldt-Jakob disease  and Fatal Familiar Insomnia compared to other Spanish autonomous communities (National Epidemiology Centre: http://www.isciii.es/htdocs/centros/epidemiologia/epidemiologia_listado_ecj.jsp).
This work indicates that AS/Nor98 constitutes the most common small ruminant Transmissible Spongiform Encephalopathy form in the Latxa breed in the Spanish Basque Country, where it also affects a genotype (ALRQ/ALRH) not previously associated to this form of TSE.
Animals and Tissues
Heads from slaughtered and fallen stock small ruminants were received at Neiker-Tecnalia. During 2002 to 2004 obex and thereafter both obex and cerebellum tissues were collected with a specifically designed sampling spoon. Sampled heads were conserved refrigerated until the results of rapid test were obtained. Portions of cerebral frontal lobe, cerebellum and medulla oblongata of positive samples were frozen at -20°C for immunoblotting analysis and other portions fixed in 10% buffered formalin prior to be embedded in paraffin according to standard procedures for immunohistochemical analysis. Four μm sections of paraffin blocks and frozen tissue were sent to the National Reference Laboratory (from 2002 to 2005 to Zaragoza, and since 2006 to Algete). In some cases, not all three brain levels were available due to autolysis or sampling problems. This protocol is part of the TSE prevention and control programme of the Basque Country.
In order to detect PrPSc in small ruminants, Bio-Rad TeSeE™ ELISA rapid test was used following manufacturer's recommendations.
The sections were treated with formic acid for 30 min and autoclaved at 121°C in 0.01 M citric acid, pH 6.1 for 30 min. Then they were submitted to a light PK digestion (4 μg/ml) at 37°C for 5 minutes prior to immunostaining using a cocktail of mAb F89/160.1.5 (VMRD, Washington, USA) and 2G11 (Institute Pourquier, France) and EnVision+ System, HRP Peroxidase-AEC (3-amino-9-ethylcarbazole) kit (DakoCytomation, California, USA). Immunostained sections were briefly counterstained with a haematoxylin solution and mounted with aquamount gel. Definition of PrPSc deposits were performed according to a previous publication .
PrP Biochemical analysis: immunoblot
Molecular characterization was performed using Prionics Check Western SR (Prionics) modified  and TeSeE Western blot (Bio-Rad). The modification of Prionics WB protocol involved the replacement of mAb 6H4 (aa 147-155, ) by P4, directed against residues 93 to 99 [63, 64] of the ovine PrP. TeSeE Western blot protocol was performed following manufacturer's recommendations as described previously .
DNA from brain samples was obtained using QIAamp DNA Mini Kit (QIAGEN). Genotyping of PrP polymorphisms at codons 136, 154 and 171 was initially carried out by real time PCR on an ABI PRISM 7000 (Applied Biosystems) as previously described  at NEIKER-Tecnalia. In addition, analysis of these codons, as well as codon 141, was carried out at the Norwegian School of Veterinary Science Oslo by DNA sequencing. The samples were amplified with the forward primer 5' AGGCTGGGGTCAAGGTGGTAGC and reverse primer 5' TGGTACTGGGTGATGCACATTTGC modified by 5' attachment of M13-21 and M13 rev tails allowing the use of commercially available fluorescence labelled primers and then sequenced using Big Dye Primer chemistry (Applied Biosystems). The polymorphisms were identified by manual inspection of the sequence electropherograms.
Comparison of the incidence of classical and atypical scrapie during the period of study was performed with the Fisher exact test of the FREQ procedure in the SAS statistical package (SAS Insitute, Inc., Cary, NC, USA).
Benestad SL, Sarradin P, Thu B, Schonheit J, Tranulis MA, Bratberg B: Cases of scrapie with unusual features in Norway and designation of a new type, Nor98. Vet Rec. 2003, 153: 202-208.
McGowan JP: Scrapie in sheep. Scottish J Agric. 1922, 5: 365-375.
Plummer PJ: Scrapie-A Disease of Sheep: A Review of the literature. Can J Comp Med Vet Sci. 1946, 10: 49-54.
Detwiler LA, Baylis M: The epidemiology of scrapie. Rev Sci Tech. 2003, 22: 121-143.
Cosseddu GM, Agrimi U, Pinto J, Schudel AA: Advances in scrapie research. Rev Sci Tech. 2007, 26: 657-668.
de Lima AC, Bossers A, Souza CE, Oliveira SM, Oliveira DM: PrP genotypes in a pedigree flock of Santa Ines sheep. Vet Rec. 2007, 160: 336-337.
Hirogari Y, Kubo M, Kimura KM, Haritani M, Yokoyama T: Two different scrapie prions isolated in Japanese sheep flocks. Microbiol Immunol. 2003, 47: 871-876.
Onodera T, Saeki K: Japanese scrapie cases. Jpn J Infect Dis. 2000, 56-61.
Shinagawa M, Matsuda A, Sato G, Takeuchi M, Ichijo S, Ono T: Occurrence of ovine scrapie in Japan: clinical and histological findings in mice inoculated with brain homogenates of an affected sheep. Nippon Juigaku Zasshi. 1984, 46: 913-916.
Luhken G, Buschmann A, Brandt H, Eiden M, Groschup MH, Erhardt G: Epidemiological and genetical differences between classical and atypical scrapie cases. Vet Res. 2007, 38: 65-80. 10.1051/vetres:2006046.
Andreoletti O, Berthon P, Marc D, Sarradin P, Grosclaude J, van Keulen LJ, Schelcher F, Elsen JM, Lantier F: Early accumulation of PrP(Sc) in gut-associated lymphoid and nervous tissues of susceptible sheep from a Romanov flock with natural scrapie. J Gen Virol. 2000, 81: 3115-3126.
van Keulen LJ, Schreuder BE, Meloen RH, Poelen-van dB, Mooij-Harkes G, Vromans ME, Langeveld JP: Immunohistochemical detection and localization of prion protein in brain tissue of sheep with natural scrapie. Vet Pathol. 1995, 32: 299-308. 10.1177/030098589503200312.
Belt PB, Muileman IH, Schreuder BE, Bos-de RJ, Gielkens AL, Smits MA: Identification of five allelic variants of the sheep PrP gene and their association with natural scrapie. J Gen Virol. 1995, 76: 509-517. 10.1099/0022-1317-76-3-509.
Hunter N, Goldmann W, Foster JD, Cairns D, Smith G: Natural scrapie and PrP genotype: case-control studies in British sheep. Vet Rec. 1997, 141: 137-140.
Laplanche JL, Chatelain J, Westaway D, Thomas S, Dussaucy M, Brugere-Picoux J, Launay JM: PrP polymorphisms associated with natural scrapie discovered by denaturing gradient gel electrophoresis. Genomics. 1993, 15: 30-37. 10.1006/geno.1993.1006.
Westaway D, Zuliani V, Cooper CM, Da Costa M, Neuman S, Jenny AL, Detwiler L, Prusiner SB: Homozygosity for prion protein alleles encoding glutamine-171 renders sheep susceptible to natural scrapie. Genes Dev. 1994, 8: 959-969. 10.1101/gad.8.8.959.
McKinley MP, Bolton DC, Prusiner SB: A protease-resistant protein is a structural component of the scrapie prion. Cell. 1983, 35: 57-62. 10.1016/0092-8674(83)90207-6.
Fediaevsky A, Gasqui P, Calavas D, Ducrot C: Discrepant epidemiological patterns between classical and atypical scrapie in sheep flocks under French TSE control measures. Vet J. 2009,
De Bosschere H, Roels S, Benestad SL, Vanopdenbosch E: Scrapie case similar to Nor98 diagnosed in Belgium via active surveillance. Vet Rec. 2004, 155: 707-708.
Moum T, Olsaker I, Hopp P, Moldal T, Valheim M, Moum T, Benestad SL: Polymorphisms at codons 141 and 154 in the ovine prion protein gene are associated with scrapie Nor98 cases. J Gen Virol. 2005, 86: 231-235. 10.1099/vir.0.80437-0.
Hopp P, Omer MK, Heier BT: A case-control study of scrapie Nor98 in Norwegian sheep flocks. J Gen Virol. 2006, 87: 3729-3736. 10.1099/vir.0.81951-0.
McIntyre KM, del RVV, Gubbins S: No temporal trends in the prevalence of atypical scrapie in British sheep, 2002-2006. BMC Vet Res. 2008, 4: 13-10.1186/1746-6148-4-13.
Simmons MM, Konold T, Simmons HA, Spencer YI, Lockey R, Spiropoulos J, Everitt S, Clifford D: Experimental transmission of atypical scrapie to sheep. BMC Vet Res. 2007, 3: 20-10.1186/1746-6148-3-20.
Le Dur A, Beringue V, Andreoletti O, Reine F, Lai TL, Baron T, Bratberg B, Vilotte JL, Sarradin P, Benestad SL, et al: A newly identified type of scrapie agent can naturally infect sheep with resistant PrP genotypes. Proc Natl Acad Sci USA. 2005, 102: 16031-16036. 10.1073/pnas.0502296102.
Espinosa JC, Herva ME, Andreoletti O, Padilla D, Lacroux C, Cassard H, Lantier I, Castilla J, Torres JM: Transgenic mice expressing porcine prion protein resistant to classical scrapie but susceptible to sheep bovine spongiform encephalopathy and atypical scrapie. Emerg Infect Dis. 2009, 15: 1214-1221. 10.3201/eid1508.081218.
Green DM, del RVV, Birch CP, Johnson J, Kiss IZ, McCarthy ND, Kao RR: Demographic risk factors for classical and atypical scrapie in Great Britain. J Gen Virol. 2007, 88: 3486-3492. 10.1099/vir.0.83225-0.
Fediaevsky A, Morignat E, Ducrot C, Calavas D: A case-control study on the origin of atypical scrapie in sheep, France. Emerg Infect Dis. 2009, 15: 710-718. 10.3201/eid1505.081119.
Buschmann A, Luhken G, Schultz J, Erhardt G, Groschup MH: Neuronal accumulation of abnormal prion protein in sheep carrying a scrapie-resistant genotype (PrPARR/ARR). J Gen Virol. 2004, 85: 2727-2733. 10.1099/vir.0.79997-0.
Gavier-Widen D, Noremark M, Benestad S, Simmons M, Renstrom L, Bratberg B, Elvander M, af Segerstad CH: Recognition of the Nor98 variant of scrapie in the Swedish sheep population. J Vet Diagn Invest. 2004, 16: 562-567.
Konold T, Davis A, Bone G, Bracegirdle J, Everitt S, Chaplin M, Saunders GC, Cawthraw S, Simmons MM: Clinical findings in two cases of atypical scrapie in sheep: a case report. BMC Vet Res. 2007, 3: 2-10.1186/1746-6148-3-2.
Nentwig A, Oevermann A, Heim D, Botteron C, Zellweger K, Drogemuller C, Zurbriggen A, Seuberlich T: Diversity in neuroanatomical distribution of abnormal prion protein in atypical scrapie. PLoS Pathog. 2007, 3: e82-10.1371/journal.ppat.0030082.
Onnasch H, Gunn HM, Bradshaw BJ, Benestad SL, Bassett HF: Two Irish cases of scrapie resembling Nor98. Vet Rec. 2004, 155: 636-637.
Buschmann A, Biacabe AG, Ziegler U, Bencsik A, Madec JY, Erhardt G, Lühken G, Baron T, Groschup MH: Atypical scrapie cases in Germany and France are identified by discrepant reaction patterns in BSE rapid tests. J Virol Methods. 2004, 117: 27-36. 10.1016/j.jviromet.2003.11.017.
Epstein V, Pointing S, Halfacre S: Atypical scrapie in the Falkland Islands. Vet Rec. 2005, 157: 667-668.
Orge L, Galo A, Machado C, Lima C, Ochoa C, Silva J, Ramos M, Simas JP: Identification of putative atypical scrapie in sheep in Portugal. J Gen Virol. 2004, 85: 3487-3491. 10.1099/vir.0.80246-0.
Benestad SL, Arsac JN, Goldmann W, Noremark M: Atypical/Nor98 scrapie: properties of the agent, genetics, and epidemiology. Vet Res. 2008, 39: 19-10.1051/vetres:2007056.
Foster J, Toovey L, McKenzie C, Chong A, Parnham D, Drummond D, Hunter N: Atypical scrapie in a sheep in a closed UK flock with endemic classical natural scrapie. Vet Rec. 2008, 162: 723-724.
Moore SJ, Simmons M, Chaplin M, Spiropoulos J: Neuroanatomical distribution of abnormal prion protein in naturally occurring atypical scrapie cases in Great Britain. Acta Neuropathol. 2008, 116: 547-559. 10.1007/s00401-008-0433-8.
Arsac JN, Andreoletti O, Bilheude JM, Lacroux C, Benestad SL, Baron T: Similar biochemical signatures and prion protein genotypes in atypical scrapie and Nor98 cases, France and Norway. Emerg Infect Dis. 2007, 13: 58-65. 10.3201/eid1301.060393.
Baylis M, Goldmann W: The genetics of scrapie in sheep and goats. Curr Mol Med. 2004, 4: 385-396. 10.2174/1566524043360672.
Luhken G, Buschmann A, Groschup MH, Erhardt G: Prion protein allele A136 H154Q171 is associated with high susceptibility to scrapie in purebred and crossbred German Merinoland sheep. Arch Virol. 2004, 149: 1571-1580. 10.1007/s00705-004-0303-1.
Moreno CR, Moazami-Goudarzi K, Laurent P, Cazeau G, Andreoletti O, Chadi S, Elsen JM, Calavas D: Which PrP haplotypes in a French sheep population are the most susceptible to atypical scrapie?. Arch Virol. 2007, 152: 1229-1232. 10.1007/s00705-007-0956-7.
Saunders GC, Cawthraw S, Mountjoy SJ, Hope J, Windl O: PrP genotypes of atypical scrapie cases in Great Britain. J Gen Virol. 2006, 87: 3141-3149. 10.1099/vir.0.81779-0.
Klingeborn M, Wik L, Simonsson M, Renstrom LH, Ottinger T, Linne T: Characterization of proteinase K-resistant N- and C-terminally truncated PrP in Nor98 atypical scrapie. J Gen Virol. 2006, 87: 1751-1760. 10.1099/vir.0.81618-0.
De Bosschere H, Roels S, Dechamps P, Vanopdenbosch E: TSE detected in a Belgian ARR-homozygous sheep via active surveillance. Vet J. 2005, 173: 449-451. 10.1016/j.tvjl.2005.07.014.
Everest SJ, Thorne L, Barnicle DA, Edwards JC, Elliott H, Jackman R, Hope J: Atypical prion protein in sheep brain collected during the British scrapie-surveillance programme. J Gen Virol. 2006, 87: 471-477. 10.1099/vir.0.81539-0.
Konold T, Bone G, Ryder S, Hawkins SA, Courtin F, Berthelin-Baker C: Clinical findings in 78 suspected cases of bovine spongiform encephalopathy in Great Britain. Vet Rec. 2004, 155: 659-666.
Konold T, Davis A, Bone GE, Simmons MM, Kahn J, Blake-Dyke MC, Bracegirdle J, Shimwell CJ: Atypical scrapie cases in the UK. Vet Rec. 2006, 158: 280.
Cook W: Nor98-like strain of scrapie found in Wyoming. Wyoming Livestock Board 2007.
Polak MP, Larska M, Langeveld JP, Buschmann A, Groschup MH, Zmudzinski JF: Diagnosis of the first cases of scrapie in Poland. Vet J. 2009,
Del Rio Vilas V, Bohning D, Kuhnert R: A comparison of the active surveillance of scrapie in the European Union. Vet Res. 2008, 39: 37-10.1051/vetres:2008014.
Fediaevsky A, Tongue SC, Noremark M, Calavas D, Ru G, Hopp P: A descriptive study of the prevalence of atypical and classical scrapie in sheep in 20 European countries. BMC Vet Res. 2008, 4: 19-10.1186/1746-6148-4-19.
Gabiña D, Arrese F, Beltrán de Heredia I, Arranz J: Average milk yields and environmental effects on Latxa sheep. J Dairy Sci. 1993, 76: 1191-1198. 10.3168/jds.S0022-0302(93)77448-2.
Ugarte E: The Breeding Program of Latxa Breed. 2nd International congress, Belgrade, October 3-5,2007. Biotechnology in Animal Husbandry 5-6. 97-111.
Berriatua E, Barandika JF, Aduriz G, Hurtado A, Estevez L, Atxaerandio R, Garcia-Perez AL: Flock-prevalence of border disease virus infection in Basque dairy-sheep estimated by bulk-tank milk analysis. Vet Microbiol. 2006, 118: 37-46. 10.1016/j.vetmic.2006.06.013.
Orge L, Acin C, Gonzalez L, Siso S, Monleon E, Casalone C, Iulini B, Badiola JJ, Gavier-Widen D, Benestad SL: Effect of long-term fixation in the immunohistochemical detection of PrPSc in atypical scrapie. Prion. 2009, 91- , Thessaloniki - Chalkidiki, Greece, 23-25 September 2009
Hurtado A, García-Perez A, Beltrán de Heredia I, Barandika J, Sanz-Parra A, Berriatua E, Juste RA: Genetic susceptibility to scrapie in a population of Latxa breed in the Basque Country, Spain. Small Rumin Res. 2002, 45: 255-259. 10.1016/S0921-4488(02)00156-6.
van Keulen LJ, Bossers A, van Zijderveld F: TSE pathogenesis in cattle and sheep. Vet Res. 2008, 39: 24-10.1051/vetres:2007061.
Calavas D, Ducrot C: Tendance récente de l'épizootie d'ESB en France et efficacité des mesures de contrôle. Bulletin Epidémiologique. 2004, 1-6. Afssa
Avellanal F, Almazán J, Martínez-Martín P, Mahillo-Fernández I, de Pedro-Cuesta J: Human Transmissible Spongiform Encephalopathies in Sapin, 1993-2008. PRION. 2008, Madrid, Spain, 24- Congress Book of Abstracts
Gomez N, Benedicto L, Geijo MV, Garrido JM, Garcia-Crespo D, Korkostegi JL, Juste RA: Use of immunodiagnostic tests on an outbreak of scrapie in Latxa sheep: Pathogenic and epidemiologic implications. Small Rumin Res. 2007, 72: 141-148. 10.1016/j.smallrumres.2006.10.007.
Korth C, Stierli B, Streit P, Moser M, Schaller O, Fischer R, Schulz-Schaeffer WJ, Kretzschmar HA, Raeber AJ, Braun U, et al: Prion (PrPSc)-specific epitope defined by a monoclonal antibody. Nature. 1997, 390: 74-77. 10.1038/36337.
Harmeyer S, Pfaff E, Groschup MH: Synthetic peptide vaccines yield monoclonal antibodies to cellular and pathological prion proteins of ruminants. J Gen Virol. 1998, 79 (Pt 4): 937-945.
Thuring CM, Erkens JH, Jacobs JG, Bossers A, van Keulen LJ, Garssen GJ, van Zijderveld FG, Ryder S, Groschup MH, Sweeney T, et al: Discrimination between Scrapie and Bovine Spongiform Encephalopathy in Sheep by Molecular Size, Immunoreactivity, and Glycoprofile of Prion Protein. J Clin Microbiol. 2004, 42: 972-980. 10.1128/JCM.42.3.972-980.2004.
Garcia-Crespo D, Oporto B, Gomez N, Nagore D, Benedicto L, Juste RA, Hurtado A: PrP polymorphisms in Basque sheep breeds determined by PCR-restriction fragment length polymorphism and real-time PCR. Vet Rec. 2004, 154: 717-722.
We thank the Livestock Services of the Diputación Foral of Alava, Bizkaia and Gipuzkoa as well as the veterinary staff in the slaughterhouses and rendering plant for facilitating sample collection and information throughout the Basque Country TSE surveillance and prevention program. We also want to thank the staff from the TSE laboratory of Neiker-Tecnalia for their contribution in sample processing. We thank the Norwegian School of Veterinary Science of Oslo for PrP genotyping at codon 141. We also acknowledge the two Spanish National Reference Centres for TSEs for the officially required confirmation of the cases. We thank Dr. Natalia Elguezabal for English language revision. This work was supported by a Support to Health Research grant of the Planning and Arranging Directorate of the Department of Health of the Basque Government (grant #2006111037).
ABRM carried out the molecular analyses, participated in the genotyping and data collection and drafted the manuscript. JMG participated in the sampling and data collection and participated in the design of the study and coordination and helped to draft the manuscript. SM, LB and MG contributed to sampling, performing of rapid test and genotyping. NG and EM carried out initial histopathological and immunohistochemical processing and interpreted the results. SLB carried out the immunohistochemical analysis of the sections with F89/160.1.5 and 2G11 and supervised the genotyping of codon 141. RJU is the head of the project and had primary responsibility in the design and supervision of the investigations reported here as well as of writing of the manuscript. All authors read and approved the final manuscript.